Drug Shortage Report for MORPHINE SULFATE INJECTION EPIDURAL

Last updated on 2025-02-22 History
Report ID 245804
Drug Identification Number 02498278
Brand name MORPHINE SULFATE INJECTION EPIDURAL
Common or Proper name MORPHINE SULFATE INJECTION EPIDURAL
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) MORPHINE SULFATE
Strength(s) 0.5MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL
Packaging size 10 VIALS X 10 ML
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-12-30
Actual start date
Estimated end date 2025-03-04
Actual end date 2025-02-21
Shortage status Resolved
Updated date 2025-02-22
Company comments Limited inventory is available at McKesson. Contract coverage is in place as needed.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2025-02-22 English Compare
v9 2025-02-21 French Compare
v8 2025-02-21 English Compare
v7 2025-01-23 French Compare
v6 2025-01-23 English Compare
v5 2025-01-09 French Compare
v4 2025-01-09 English Compare
v3 2024-12-31 English Compare
v2 2024-12-16 French Compare
v1 2024-12-16 English Compare

Showing 1 to 10 of 10